We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-20.08%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$21.4B
AUM Growth
-$9.89B
(-32%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-12.81%
Top 10 Holdings %
Top 10 Hldgs %
28.78%
Holding
568
New
77
Increased
161
Reduced
233
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$219M |
| 2 |
Live Nation Entertainment
LYV
|
+$180M |
| 3 |
Datadog
DDOG
|
+$175M |
| 4 |
Costco
COST
|
+$165M |
| 5 |
Trade Desk
TTD
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$349M |
| 2 |
Apple
AAPL
|
+$337M |
| 3 |
Microsoft
MSFT
|
+$232M |
| 4 |
XPO
XPO
|
+$146M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.04% |
| 2 | Healthcare | 20.62% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Industrials | 10.49% |
| 5 | Financials | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Halozyme
HALO
$9.9B
| $442K | ﹤0.01% |
+10,050
| New | +$435K |
|
402
MaxCyte
MXCT
$112M
| $434K | ﹤0.01% |
91,759
-1,835
| -2% | -$9.04K |
|
403
Vinci Compass Investments Ltd
VINP
$644M
| $433K | ﹤0.01% |
40,470
-8,500
| -17% | -$98.8K |
|
404
Arhaus
ARHS
$1.12B
| $425K | ﹤0.01% |
94,341
-1,846
| -2% | -$12.1K |
|
405
Xylem
XYL
$29.2B
| $421K | ﹤0.01% |
5,388
-362
| -6% | -$29.9K |
|
406
SBA Communications
SBAC
$18.6B
| $379K | ﹤0.01% |
1,183
-461
| -28% | -$155K |
|
407
Sana Biotechnology
SANA
$916M
| $370K | ﹤0.01% |
+57,506
| New | +$366K |
|
|
SOVO
408
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $367K | ﹤0.01% |
+23,122
| New | +$336K |
|
409
Allegion
ALLE
$13.7B
| $360K | ﹤0.01% |
3,677
| – | – |
|
410
Kura Oncology
KURA
$826M
| $349K | ﹤0.01% |
+19,054
| New | +$274K |
|
411
W.W. Grainger
GWW
$66B
| $330K | ﹤0.01% |
727
+689
| +1,813% | +$335K |
|
412
Freeport-McMoran
FCX
$88.6B
| $327K | ﹤0.01% |
11,181
-1,363,594
| -99% | -$54.6M |
|
413
Rockwell Automation
ROK
$52.4B
| $319K | ﹤0.01% |
1,603
| – | – |
|
|
RPTX
414
DELISTED
Repare Therapeutics
RPTX
| $319K | ﹤0.01% |
+22,772
| New | +$268K |
|
415
Standard BioTools
LAB
$311M
| $313K | ﹤0.01% |
195,490
-204,798
| -51% | -$507K |
|
416
Levi Strauss
LEVI
$9.8B
| $300K | ﹤0.01% |
18,405
| – | – |
|
417
Cartesian Therapeutics
RNAC
$225M
| $290K | ﹤0.01% |
+7,374
| New | +$219K |
|
|
TBIO
418
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $275K | ﹤0.01% |
8,503
-174
| -2% | -$12K |
|
419
Align Technology
ALGN
$12.6B
| $272K | ﹤0.01% |
1,151
| – | – |
|
420
Workday
WDAY
$39.4B
| $267K | ﹤0.01% |
1,910
| – | – |
|
421
Denali Therapeutics
DNLI
$3.82B
| $264K | ﹤0.01% |
+8,983
| New | +$235K |
|
422
Veracyte
VCYT
$4.44B
| $258K | ﹤0.01% |
+12,943
| New | +$261K |
|
|
IGMS
423
DELISTED
IGM Biosciences
IGMS
| $218K | ﹤0.01% |
12,067
-73,542
| -86% | -$1.31M |
|
424
Biodesix
BDSX
$218M
| $215K | ﹤0.01% |
6,545
-131
| -2% | -$4.26K |
|
425
Brilliant Earth
BRLT
$18.4M
| $209K | ﹤0.01% |
43,998
-863
| -2% | -$5.42K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2022 Portfolio in Review
As of Q2 2022, Fred Alger Management held 568 positions worth $21.4B, down 32% from $31.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Fred Alger Management withdrew a net $2.74B in Q2 2022, closing 68 positions and reducing 233 holdings. Its most notable exit was Expedia Group, an estimated $134M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in ServiceNow worth $132M.
- Fred Alger Management's largest Q2 2022 buy was ServiceNow: 1,388,500 shares worth $132M.
- Fred Alger Management added most to McKesson in Q2 2022, an estimated $219M increase.
- Fred Alger Management's biggest Q2 2022 reduction was NVIDIA, cutting an estimated $349M.
- Fred Alger Management fully exited Expedia Group in Q2 2022, selling an estimated $134M.
- Fred Alger Management's ten largest holdings make up 29% of its $21.4B portfolio in Q2 2022.
- Fred Alger Management opened 77 new positions and closed 68 in Q2 2022.
- Fred Alger Management's portfolio value fell 32% quarter-over-quarter to $21.4B.
Based on Fred Alger Management's 13F filing for Q2 2022, filed 15 Aug 2022.